Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 63
Filtrar
1.
Ugeskr Laeger ; 153(30): 2102-4, 1991 Jul 22.
Artigo em Dinamarquês | MEDLINE | ID: mdl-1866810

RESUMO

Rotavirus and Respiratory Syncytial virus are common causes of acute gastroenteritis and upper and lower respiratory diseases among infants and toddlers. Both viruses occur as epidemics during the winter season. The symptoms may be quite severe and often lead to hospitalisation in paediatric wards i.e. about 2,000 children per year. The viruses frequently give rise to nosocomial infections in the infant/toddler wards about one third of the cases being nosocomial. Recent studies have revealed that both viruses are spread via contaminated hands. The density of virus in faeces and upper respiratory secretions is very high less than one microgram being sufficient for spread of the disease. The traditional precautions (i.e. handwashing and isolation) have failed to reduce the numbers of nosocomial infections to an acceptable level. However, the routine use of gloves have been shown to reduce the spread of RS virus effectively. This method is suggested in paediatric wards during the winter since it presumably will also reduce the spread of Rotavirus.


Assuntos
Infecção Hospitalar/epidemiologia , Vírus Sinciciais Respiratórios , Infecções por Respirovirus/epidemiologia , Infecções por Rotavirus/epidemiologia , Criança , Pré-Escolar , Infecção Hospitalar/microbiologia , Infecção Hospitalar/prevenção & controle , Dinamarca/epidemiologia , Gastroenterite/epidemiologia , Gastroenterite/microbiologia , Departamentos Hospitalares , Humanos , Lactente , Pediatria , Vírus Sinciciais Respiratórios/isolamento & purificação , Infecções Respiratórias/epidemiologia , Infecções Respiratórias/microbiologia , Infecções Respiratórias/transmissão , Infecções por Respirovirus/prevenção & controle , Infecções por Respirovirus/transmissão , Infecções por Rotavirus/prevenção & controle , Infecções por Rotavirus/transmissão
2.
Ugeskr Laeger ; 157(7): 901, 1995 Feb 13.
Artigo em Dinamarquês | MEDLINE | ID: mdl-7701654

RESUMO

Lyme borreliosis may cause a wide range of clinical symptoms. The two previously described paediatric cases of Lyme borreliosis with symptoms of pseudotumor cerebri were associated with characteristic cutaneous symptoms. A case of seven year-old girl with six weeks of headache, vomiting nausea and fatigue as the only symptoms was shown to suffer from pseudotumor cerebri with papilloedema and increased intracranial pressure caused Borrelia burgdorferi. Specific treatment with intravenous penicillin and later intravenous ceftriaxone (due to development of penicillin allergy) for a total of ten days caused the symptoms to gradually disappear over following three to four weeks. Hence, even if pseudotumor cerebri is the only symptom, it is recommended that testing for Lyme borreliosis should be carried out.


Assuntos
Doença de Lyme/complicações , Pseudotumor Cerebral/microbiologia , Ceftriaxona/administração & dosagem , Criança , Diagnóstico Diferencial , Feminino , Humanos , Injeções Intravenosas , Doença de Lyme/diagnóstico , Doença de Lyme/tratamento farmacológico , Penicilinas/administração & dosagem , Pseudotumor Cerebral/diagnóstico , Pseudotumor Cerebral/tratamento farmacológico
3.
Ugeskr Laeger ; 161(26): 4008-9, 1999 Jun 28.
Artigo em Dinamarquês | MEDLINE | ID: mdl-10402938

RESUMO

The first diagnosed case of glucose-galactose malabsorption (GGM) in Denmark is presented. GGM is an autosomal recessive disorder characterized by neonatal début of severe osmotic diarrhoea. Untreated, GGM is potentially fatal. The disease is chronic and caused by a defect in the Na+/glucose co-transporter, SGLT1, located on the jejunal brush border. Diagnosis is based upon oral glucose tolerance test, stool reducing substances, and may be substantiated by genetic analysis. Treatment consists in eliminating alimentary glucose and galactose. Nurtured on this diet the patient will develop normally.


Assuntos
Galactose/metabolismo , Glucose/metabolismo , Síndromes de Malabsorção/diagnóstico , Diagnóstico Diferencial , Diarreia Infantil/diagnóstico , Humanos , Lactente , Recém-Nascido , Síndromes de Malabsorção/dietoterapia , Síndromes de Malabsorção/genética
4.
Ugeskr Laeger ; 155(50): 4083-6, 1993 Dec 13.
Artigo em Dinamarquês | MEDLINE | ID: mdl-8273227

RESUMO

During a six-year period, 29 children (aged 0.7-13.5 years, mean 3.3 years) suffering from chronic diarrhoea due to giardiasis were studied. The incidence of this illness was 81 per 1,000,000 per year among children aged 0- < 7 years. According to growth charts, relative height and weight of the patients decreased significantly (both approximately 0.5 SD) from before the onset of diarrhoea to the time of diagnosis and subsequently increased up to the end of catch-up growth. Small intestinal mucosal specimens were studied. Two patients had severe villous atrophy, 8 moderate abnormalities, 6 only slight changes and 13 biopsies were normal. D-xylose or lactose malabsorption was detected in 25% of the patients. The lactose malabsorption was due to hereditary low lactase levels. None of the patients with a Danish ethnic background showed lactose malabsorption. D-xylose absorption and the relative weight loss of the patients correlated with the degree of mucosal damage. Patients with persistent diarrhoea (n = 19) were younger and had a shorter duration of diarrhoeal illness and a more significant weight reduction than those with intermittent diarrhoea (n = 10). However, the age at onset of symptoms was similar in the two groups (medians 1.3 years). Seven patients contracted the disease abroad. They all developed persistent diarrhoea and had a more severe course of the illness than those who acquired the disease in Denmark.


Assuntos
Diarreia/microbiologia , Giardíase/diagnóstico , Crescimento , Intestino Delgado/patologia , Adolescente , Criança , Pré-Escolar , Doença Crônica , Dinamarca/epidemiologia , Diarreia/epidemiologia , Diarreia/patologia , Feminino , Giardíase/epidemiologia , Giardíase/patologia , Humanos , Incidência , Lactente , Mucosa Intestinal/patologia , Intestino Delgado/microbiologia , Masculino
5.
Ugeskr Laeger ; 151(6): 366-8, 1989 Feb 06.
Artigo em Dinamarquês | MEDLINE | ID: mdl-2919455

RESUMO

Meconium ileus equivalent (MIE) can be defined as a clinical manifestation in cystic fibrosis (CF) patients caused by acute intestinal obstruction by putty-like faecal material in the cecum or terminal ileum. A broader definition includes a more chronic condition in CF patients with abdominal pain and a coecal mass which may eventually pass spontaneously. The condition occurs only in CF patients with exocrine pancreatic insufficiency (EPI). It has not been seen in other CF patients nor in non-CF patients with EPI. The frequency of these symptoms has been reported as 2.4%-25%. Pathophysiologically, MIE is probably caused by a combination of EPI, increased intestinal transit time, and abnormal intestinal mucus. The treatment should primarily be non-operative. Specific treatment with N-acetylcysteine, administrated orally and/or as an enema is recommended. Enemas with the water soluble contrast medium, meglucamine diatrizoate (Gastrografin), provide an alternative form for treatment and can also serve diagnostic purposes. It is important that the physician is familiar with this disease entity and the appropriate treatment with the above mentioned drugs. Non-operative treatment is often effective, and dangerous complications following surgery can thus be avoided.


Assuntos
Obstrução Intestinal/diagnóstico , Adulto , Fibrose Cística/complicações , Impacção Fecal/etiologia , Humanos , Obstrução Intestinal/etiologia , Masculino
6.
Ugeskr Laeger ; 157(41): 5707-11, 1995 Oct 09.
Artigo em Dinamarquês | MEDLINE | ID: mdl-7571107

RESUMO

The purpose of the study was during a three year period from 1990 to 1992 to describe the neonatal mortality, morbidity and the late complications of 75 very low birth weight infants primarily treated in the neonatal department of a County Hospital. The study was performed retrospectively. The mean birth weight was 1292 g in (range 755-2046 g) and the mean gestational age 29.9 weeks (range 25-37 weeks). The primary choice of treatment was nasal continuous positive airway pressure (nasal-CPAP) and "minimal handling" regime. When needed surfactant administration and/or mechanical ventilation was used. Twenty neonates (27%) received mechanical ventilation, and 14 (19%) were treated with surfactant (Curosurf). The mortality (8%) (95% confidence limits 2.9%-16.6%) and morbidity is low. Late complications such as cerebral palsy or mental retardation were seen in eight infants (12.1%) (95% confidence limits 5.4-22.5%). The results of our treatment seem acceptable, and confirm an increasing survival among very low birth weight infants.


Assuntos
Mortalidade Infantil , Doenças do Prematuro/epidemiologia , Recém-Nascido de muito Baixo Peso , Paralisia Cerebral/etiologia , Desenvolvimento Infantil , Dinamarca/epidemiologia , Idade Gestacional , Humanos , Lactente , Recém-Nascido , Doenças do Prematuro/mortalidade , Deficiência Intelectual/etiologia , Terapia Intensiva Neonatal , Estudos Retrospectivos
7.
Nat Nanotechnol ; 14(10): 907-910, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-31582830
18.
J Pediatr Gastroenterol Nutr ; 9(3): 335-41, 1989 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-2614620

RESUMO

The fractional folic acid absorption (FAFol) was determined in 66 patients with various gastrointestinal diseases by a double-isotope technique, employing a single stool sample test (SSST) as well as a complete stool collection. The age of the patients ranged from 2.5 months to 16.8 years (mean 6.3 years). The test dose was administered orally and consisted of 50 micrograms of [3H]folic acid (monoglutamate) (approximately 20 muCi), carmine powder, and 2 mg 51CrCl3 (approximately 1.25 muCi) as the unabsorbable tracer. The whole-body radiation given to a 1-year-old child averaged 4.8 mrad only. The stool and napkin contents were collected and homogenized by the addition of 300 ml chromium sulfuric acid. A 300-ml sample of the homogenized stool and napkin contents, as well as 300 ml chromium sulfuric acid (75% vol/vol) containing the standards, were counted for the content of 51Cr in a broad-based well counter. The quantity of [3H]folic acid was determined by liquid scintillation, after duplicate distillation. Estimated by SSST, the FAFol, which employs the stool with the highest content of 51Cr corresponding to the most carmine-colored stool, correlated closely with the FAFol based on complete stool collection (r = 0.96, n = 39, p less than 0.0001). The reproducibility of FAFol determined by SSST was assessed from repeated tests in 18 patients. For a mean of 81%, the SD was 4.6%, which corresponded to a coefficient of variation of 5.7%.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Fezes/análise , Ácido Fólico/farmacocinética , Absorção Intestinal , Adolescente , Adulto , Criança , Pré-Escolar , Radioisótopos de Cromo , Ácido Fólico/análise , Humanos , Lactente , Trítio
19.
J Pediatr Gastroenterol Nutr ; 5(2): 268-73, 1986.
Artigo em Inglês | MEDLINE | ID: mdl-3958853

RESUMO

The fractional vitamin B12 absorption (FAB12) was determined in 39 patients with various gastrointestinal diseases by a double-isotope technique, employing a single stool sample test (SSST), as well as a complete stool collection. The age of the patients ranged from 2.5 months to 16.2 years (mean 5.0 years). The test dose was administered orally and consisted of 0.5-4.5 micrograms of 57CoB12 (approximately 0.05 microCi), carmine powder, and 2 mg 51CrCl3 (approximately 1.25 microCi) as the inabsorbable tracer. The wholebody radiation to a 1-year-old child averaged only 20 mrad. The stool and napkin was collected and homogenized by addition of 300 ml "chromium sulfuric acid." A 300-ml sample of the homogenized stool and napkin, as well as 300 ml chromium sulfuric acid (75% v/v) containing the standards, were counted in a broad-based well counter. The FAB12 determined by SSST employing the stool with the highest content of 51Cr (which corresponded to the most carmine-colored stool) correlated closely to the FAB12 based on complete stool collection (r = 0.98, n = 39, p less than 0.001). The reproducibility of FAB12 determined by SSST was assessed from double assays in 19 patients. For a mean value of 12%, the SD was 3%, which corresponded to a coefficient of variation (CV) of 25%. The excretion of 57Co and 51Cr in the urine was examined in six patients with moderate to severe mucosal damage and was found to be low.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Cloretos , Compostos de Cromo , Cromo , Radioisótopos de Cobalto , Fezes/análise , Absorção Intestinal , Vitamina B 12/metabolismo , Adolescente , Criança , Pré-Escolar , Cromo/metabolismo , Radioisótopos de Cromo/urina , Radioisótopos de Cobalto/urina , Estudos de Avaliação como Assunto , Gastroenteropatias/metabolismo , Motilidade Gastrointestinal , Humanos , Lactente
20.
J Pediatr Gastroenterol Nutr ; 13(1): 27-31, 1991 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-1919949

RESUMO

The fractional absorption of vitamin B12 (FAB12) was measured by a double-isotope technique specially adapted for children. In six celiac children on a strict gluten-free diet and with a normal small intestinal biopsy, the FAB12 performed in the fasting patient averaged 30% (23-40%). After gluten challenge for a mean of 2 months (range 1-4), when mucosal damage was demonstrated by biopsy, the average fasting FAB12 in these patients decreased to 10% (0-17%) (p less than 0.05). However, when the FAB12 test was repeated by means of stimulation by a B12-free meal 1-3 weeks later, while the patients were still on a diet containing gluten, a significant increase was observed (mean 21%, range 14-27%) (p less than 0.05). In four of the six patients the B12 absorption was further evaluated by repeating the FAB12 test by means of intravenous cholecystokinin (CCK) stimulation (n = 3) or by administration of exocrine pancreas enzyme supplementation (EPES) (n = 2) or cobinamide (n = 1). These tests all showed FAB12 values within the range of the meal-stimulated FAB12. Moreover, in eight gluten-free celiac children with normal biopsies, no difference was found between fasting and meal-stimulated FAB12 values. Therefore, it is likely that the early-onset B12 malabsorption observed in the gluten-challenged celiac child with upper-small-intestinal mucosal damage is in part due to an insufficient stimulation of the exocrine pancreas when using the standard fasting B12 absorption test.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Doença Celíaca/complicações , Glutens/administração & dosagem , Absorção Intestinal/fisiologia , Pâncreas/fisiopatologia , Deficiência de Vitamina B 12/fisiopatologia , Adolescente , Doença Celíaca/fisiopatologia , Criança , Pré-Escolar , Humanos , Lactente , Deficiência de Vitamina B 12/etiologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa